AI Assistant
Blog
Pricing
Log In
Sign Up
Monotherapy with pembrolizumab in the first-line treatment of non-small cell lung cancer with a high expression of PD-L1 ≥ 50 %
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
